On the afternoon of May 7th, 2021, in order to strengthen the regenerative medicine and technical cooperation, accelerate the development of regenerative medicine industry and landing, fully integrated advantages of both sides, is focused on the regeneration medical, biological, pharmaceutical, etc advantages, the construction features of regenerative medicine the regenerative medicine industry alliance of the preparatory committee in chengdu high-tech biological bureau meeting successfully.

The preparatory meeting of china-japan Regenerative Medicine Industry Alliance is in progress

Tian Jun, Deputy Director of Biological Industry Bureau of Chengdu High-tech Zone, Huang Pengyu, Deputy Director of Biological Industry Bureau of Chengdu High-tech Zone, Masaji Yokojing, General Manager and Ma Gang, Deputy General manager of Ledun Investment (China) Co., LTD., Zeng Bin, Deputy Secretary-general of Chengdu High-tech Medical Association and Ai He, deputy secretary-general of Chengdu High-tech Medical Association attended the meeting.

Masaki Yokai, General Manager of Radun Investment (China) Co., LTD

First of all, General Manager Masaki Yokai of Radun Investment (China) Co., LTD., explained the current development status of the company, the industry situation, the next step of the company's planning and the direction of bilateral cooperation in the later period.

At the meeting, Tian Jun, Deputy Director general of the Regenerative medicine Alliance, fully discussed and communicated on academic exchange of regenerative medicine innovation, evaluation of investment projects, (evaluation), organizational structure of regenerative medicine Alliance, industrial policy dynamics, cooperation areas, strengthening bilateral cooperation, personnel training, transformation of scientific and technological achievements and reached consensus.

Finally, Secretary General Zeng Bin pointed out that the construction of regenerative medicine Industry Alliance is the starting point for promoting the vigorous development of regenerative medicine. It is necessary to promote international academic exchanges, technical exchanges and resource integration, accelerate the implementation of industrial projects, expand the scale of the industry and promote the trade of relevant scientific and technological achievements.

Regenerative medicine is a frontier field of medical development, with broad prospects for development, and also a future opportunity for the bio-industry of Chengdu High-tech Zone to focus on exploration. Japan has internationally leading advantages in regenerative medicine research and industry. With the medical frontier science and technology undertaking entering a new era of development, strengthening cooperation and platform construction will effectively promote the research and innovation in this field and accelerate the practical application of scientific research achievements in the medical field, and also play an important role in promoting the training of scientific research reserve talents.

The discussion at the Chengdu China-Japan Regenerative Medicine Alliance preparatory meeting will set up an exchange platform in the field of regenerative medicine between China and Japan, help both sides to give full play to their respective advantages, strengthen cooperation in medical technology, achievement transformation, industrial landing and other aspects, and promote the innovation and development of the medical and health industry.